Zepbound FDA Approval News

Update: 2023-11-10

Description

All the things you *really* want to know about Zepbound, the newest medication to be FDA-approved for chronic weight management, with Dr. Spencer Nadolsky, WeightWatchers Medical Director and lipid specialist certified with the American Board of Obesity Medicine.

Comments

In Channel

Zepbound FDA Approval News

2023-11-1036:09

Using Nutrition to Support Sustainable Weight Loss

2023-11-0215:22

PCOS, Fertility, and GLP-1s

2023-10-3121:18

Weight Bias & Stigma in Obesity Medicine

2023-10-2621:44

History of Weight Management Medications

2023-10-2435:00

Exercise Physiology & Health Promotion

2023-10-1921:55

Understanding Emotional Eating

2023-10-1717:58

Setting Sustainable Nutrition Goals

2023-10-1220:26

The Psychology of Weight Loss

2023-10-1021:36

Optimizing Nutrition after Bariatric Surgery

2023-10-0520:13

Science of Nutrition with Dr. Michelle Cardel

2023-10-0327:21

Weight Loss with PCOS and Hashimoto's | Kailey's Story

2023-09-2828:18

The Optimal Exercise for Weight Loss

2023-09-2621:26

GLP-1 Research: BED and Addiction Studies

2023-09-2114:34

Maintenance on a GLP-1 Medication

2023-09-1927:23

Bariatric Nutrition with Jamie Mills, RDN

2023-09-1431:59

The Biggest Loser Study

2023-09-1222:03

How Lifestyle Affects Weight

2023-09-0727:50

April's Experience on a GLP-1 Medication

2023-09-0527:30

Hyper & Hypo Responders to GLP-1 Medicines

2023-08-3126:23

00:00

Zepbound FDA Approval News

Dr. Spencer Nadolsky and WeightWatchers Clinic

#box-pro-ellipsis-175996322525090{-webkit-line-clamp:2;}Zepbound FDA Approval News

Zepbound FDA Approval News

Dr. Spencer Nadolsky and WeightWatchers Clinic

Zepbound FDA Approval News